NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
申请人:MANOHARAN Muthiah
公开号:US20120095075A1
公开(公告)日:2012-04-19
The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells. In particular, the invention provides lipids having the following structure:
本发明提供了有利于用于体内向细胞传递治疗剂的脂质。具体而言,本发明提供具有以下结构的脂质:
Lipids and compositions for the delivery of therapeutics
申请人:Arbutus Biopharma Corporation
公开号:US10835612B2
公开(公告)日:2020-11-17
The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells. In particular, the invention provides lipids having the following structures:
本发明提供的脂质可用于脂质微粒中,有利于向细胞体内输送治疗剂。本发明尤其提供具有以下结构的脂质:
Noncovalent Secondary Interactions in Co(II)Salen Complexes: O<sub>2</sub> Binding and Catalytic Activity in Cyclohexene Oxygenation
作者:Roberto Fiammengo、Christiaan M. Bruinink、Mercedes Crego-Calama、David N. Reinhoudt
DOI:10.1021/jo026118a
日期:2002.11.1
The O-2 affinity of Co(II)Salen complexes 1-4 and their reactivity in cyclohexene oxygenation reactions of Co(II)Salen complexes 1-4 are modulated by noncovalent interactions such as hydrogen bonding and steric hindrance using a functionalized diamino bridge. Higher O-2 affinity is observed in the case of efficient hydrogen-bonding interactions (complex 1), while increased steric hindrance (cis vs trans diamino bridge) around the Co-coordinated O-2 is influencing the reactivity of the complexes.